Related Experiment Video
Updated: Jun 14, 2026

Transverse Aortic Constriction in Mice
Published on: April 21, 2010
MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart
John M Streicher1, Shuxun Ren, Harvey Herschman
1Department of Anesthesiology, David Geffen School of Medicine, University of California, Los Angeles, CA 91301, USA.
Rationale:
Activation of p38 mitogen-activated protein kinase (MAPK) has a significant impact on cardiac gene expression, contractility, extracellular matrix remodeling, and inflammatory response in heart. The p38 kinase pathway also has a controversial role in cardiac hypertrophy. MAPK-activated protein kinase-2 (MK2) is a well-established p38 downstream kinase, yet its contribution to p38-mediated pathological response in heart has not been investigated.
Objective:
We examined the specific contribution of MK2 to the pathological remodeling induced by p38.
Methods And Results:
We used a cardiomyocyte specific and inducible transgenic approach to determine the functional and molecular impact of acute activation of the p38 pathway in heart in either a MK2 wild-type or a MK2-null background. p38 activation in wild-type mice led to a rapid onset of lethal cardiomyopathy associated with cardiomyocyte hypertrophy, interstitial fibrosis, and contractile dysfunction. Inactivation of MK2 partially but significantly reduced cardiomyocyte hypertrophy, improved contractile performance, and prevented early lethality. MK2 inactivation had no effect on the mRNA levels of hypertrophic marker genes or the proinflammatory gene cyclooxygenase (COX)-2. However, MK2 had a major role in COX-2 protein synthesis without affecting the mRNA level or protein stability.
Conclusions:
p38 activity in adult myocytes can contribute to pathological hypertrophy and remodeling in adult heart and that MK2 is an important downstream molecule responsible for specific features of p38-induced cardiac pathology.
Insights
p38 activation in heart causes lethal cardiomyopathy, but inactivating its downstream kinase, MAPK-activated protein kinase-2 (MK2), partially prevents this. MK2 plays a key role in p38-induced cardiac pathology.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Signal Transduction
Background:
- p38 mitogen-activated protein kinase (MAPK) influences cardiac gene expression, contractility, and inflammation.
- The role of p38 in cardiac hypertrophy is debated.
- MAPK-activated protein kinase-2 (MK2) is a downstream kinase of p38, but its role in cardiac pathology is unknown.
Purpose of the Study:
- To investigate the specific contribution of MK2 to p38-induced pathological cardiac remodeling.
- To elucidate the downstream mechanisms by which p38 signaling affects the heart.
Main Methods:
- Utilized a cardiomyocyte-specific, inducible transgenic mouse model.
- Compared p38 activation effects in wild-type and MK2-null backgrounds.
- Assessed cardiac function, hypertrophy, fibrosis, gene expression, and protein synthesis.
Main Results:
- p38 activation in wild-type mice induced lethal cardiomyopathy with hypertrophy, fibrosis, and dysfunction.
- MK2 inactivation partially rescued cardiomyocyte hypertrophy, improved contractility, and prevented lethality.
- MK2 was crucial for COX-2 protein synthesis, independent of mRNA levels or protein stability.
Conclusions:
- p38 signaling in adult cardiomyocytes contributes to pathological cardiac hypertrophy and remodeling.
- MK2 is a significant downstream mediator of p38-induced cardiac pathology, particularly in protein synthesis regulation.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
MAPK Signaling Cascades
Cellular Adaptation II: Hypertrophy
GPCRs Regulate Adenylyl Cylase Activity
Two...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
